Haegarda Will Join Cinryze for Hereditary Angioedema

You'll hear about Haegarda (hay-GAR-duh), a new med to prevent "hereditary angioedema" attacks.

Think of Haegarda as similar to Cinryze. They're both "C1 esterase inhibitors" that are injected twice weekly to keep swelling from this rare genetic disorder at bay.

But be aware of a difference with Haegarda. It's given subcutaneously instead of IV like Cinryze.

Get unlimited access through an Enterprise license

Hospital Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals